GlassScriptPhysician profile
Rachel Weaver
NPI 1073923967
$1,705.54
in general payments reported to CMS, 2019-2025
23 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $118 · 2021: $132 · 2022: $253 · 2023: $527 · 2024: $329 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.35 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $457.37 | 2019-2023 | Lo Loestrin Fe, Liletta, Orilissa |
| Astellas Pharma US INC | $307.63 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $93.84 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $76.27 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $75.20 | 2023-2024 | |
| Mylan Pharmaceuticals INC. | $71.06 | 2019-2020 | |
| Agile Therapeutics, INC. | $69.84 | 2022-2024 | Twirla |
| Myriad Women'S Health, INC. | $61.40 | 2023 | |
| Organon LLC | $60.51 | 2023-2025 | Nexplanon |
| Exeltis, USA INC. | $56.52 | 2020-2025 | Slynd, Nuvessa |
| Caldera Medical, INC | $53.39 | 2022 | |
| Hologic Sales and Service, LLC | $46.59 | 2023-2024 | Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $36.23 | 2020 | |
| Scynexis, INC. | $34.19 | 2022 | |
| Medtronic, INC. | $33.22 | 2022-2024 | Ligasure |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $30.97 | 2023-2025 | |
| Atricure, INC. | $30.58 | 2023 | |
| Conmed Corporation | $24.80 | 2022 | |
| Lupin INC. | $21.65 | 2019 | |
| Pfizer INC. | $21.24 | 2024 | |
| Daiichi Sankyo INC. | $15.87 | 2019 | |
| Coopersurgical, INC. | $13.85 | 2022 | |
| Optumhealth Care Solutions, LLC | $13.32 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.